Research graph
References from Optimizing Early Clinical Management of Herpes Zoster to Prevent Postherpetic Neuralgia: An Evidence‐Based Narrative Review. Local targets link to admitted publications; unresolved targets remain external evidence.
Herpes Zoster Epidemiology, Management, and Disease and Economic Burden in Europe: A Multidisciplinary Perspective
10.1177/2051013615599151 · 2015 · External reference
Systematic Review of Incidence and Complications of Herpes Zoster: Towards a Global Perspective
10.1136/bmjopen-2014-004833 · 2014 · External reference
The Global Epidemiology of Herpes Zoster
10.1212/wnl.0b013e3182a3516e · 2013 · External reference
Herpes Zoster
10.1056/nejmcp1302674 · 2013 · External reference
The Epidemiology and Natural History of Herpes Zoster and Postherpetic Neuralgia
2002 · External reference
The Impact of Herpes Zoster and Postherpetic Neuralgia on Health‐Related Quality of Life: A Prospective Study
10.1503/cmaj.091711 · 2010 · External reference
Herpes Zoster Pathogenesis and Cell‐Mediated Immunity and Immunosenescence
2009 · External reference
Recommendations for the Management of Herpes Zoster
10.1086/510206 · 2007 · External reference
Herpes Zoster and Postherpetic Neuralgia: Prevention and Management
2017 · External reference
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
10.1056/nejmoa1501184 · 2015 · External reference
Risk Factors for Herpes Zoster: A Systematic Review and Meta‐Analysis
10.1016/j.mayocp.2017.10.009 · 2017 · External reference
Risk Factors for Herpes Zoster Infection: A Meta‐Analysis
10.1093/ofid/ofaa005 · 2020 · External reference
Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2008 · External reference
What Does Epidemiology Tell Us About Risk Factors for herpes Zoster?
10.1016/s1473-3099(03)00857-0 · 2004 · External reference
Herpes Zoster and Postherpetic Neuralgia: Incidence and Risk Indicators Using a General Practice Research Database
10.1093/fampra/19.5.471 · 2002 · External reference
Immune Senescence and Vaccines to Prevent Herpes Zoster in Older Persons
10.1016/j.coi.2012.06.002 · 2012 · External reference
The Incidence of Herpes Zoster in a United States Administrative Database
10.1111/j.1525-1497.2005.0150.x · 2005 · External reference
Varicella Zoster Virus in the Nervous System
10.12688/f1000research.7153.1 · 2015 · External reference
The Relationship Between herpes Zoster and Stroke
10.1007/s11910-015-0534-4 · 2015 · External reference
Unresolved reference
2001 · External reference
Mechanisms of Pain and Itch Caused by Herpes Zoster (Shingles)
10.1016/j.jpain.2007.10.003 · 2008 · External reference
Advances in the Understanding of the Pathogenesis and Epidemiology of herpes Zoster
10.1016/s1386-6532(10)70002-0 · 2010 · External reference
Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
10.1097/aln.0000000000002130 · 2018 · External reference
Mechanisms of Disease: Neuropathic Pain—A Clinical Perspective
10.1038/ncpneuro0113 · 2006 · External reference
Central Sensitization: Implications for the Diagnosis and Treatment of Pain
10.1016/j.pain.2010.09.030 · 2011 · External reference
Mechanisms of Neuropathic Pain
10.1016/j.neuron.2006.09.021 · 2006 · External reference
Postherpetic Neuralgia
10.1056/nejmcp1403062 · 2014 · External reference
A Systematic Review and Meta‐Analysis of Risk Factors for Postherpetic Neuralgia
10.1097/j.pain.0000000000000307 · 2016 · External reference
Incidence of Herpes Zoster in Patients With Altered Immune Function
2014 · External reference
Herpes Zoster
10.1056/nejmcp013211 · 2002 · External reference
Varicella Zoster Virus (VZV) in Solid Organ Transplant Recipients
10.1111/j.1600-6143.2009.02901.x · 2009 · External reference
Risk Factors for Postherpetic Neuralgia in Patients With Herpes Zoster
10.1212/01.wnl.0000123261.00004.29 · 2004 · External reference
Treatment of Acute Herpes Zoster: Effect of Early (48 h) Therapy With Acyclovir and Valacyclovir on Prolonged Pain
10.1086/514271 · 1998 · External reference
Neurologic Complications of the Reactivation of Varicella–Zoster Virus
10.1056/nejm200003023420906 · 2000 · External reference
Evidence of Central Sensitization in Postherpetic Neuralgia
2003 · External reference
The Impact of Herpes Zoster and Post‐Herpetic Neuralgia on Quality‐of‐Life
10.1186/1741-7015-8-37 · 2010 · External reference
NOSOLOGICAL ENTITIES?: Ramsay Hunt Syndrome
10.1136/jnnp.71.2.149 · 2001 · External reference
Varicella‐Zoster Virus: Atypical Presentations and Unusual Complications
10.1086/342963 · 2002 · External reference
Laboratory Diagnosis of Herpes Simplex and Varicella‐Zoster Virus Infections
2002 · External reference
Interventions to Prevent Postherpetic Neuralgia: Cutaneous and Percutaneous Techniques
10.1016/j.pain.2003.10.021 · 2004 · External reference
Herpes Zoster in Older Adults
10.1086/320169 · 2001 · External reference
Varicella Zoster Virus Vasculopathies: Diverse Clinical Manifestations, Laboratory Features, Pathogenesis, and Treatment
10.1016/s1474-4422(09)70134-6 · 2009 · External reference
Gender as an Independent Risk Factor for Herpes Zoster: A Population‐Based Prospective Study
10.1016/j.annepidem.2005.12.002 · 2006 · External reference
Neuronal Plasticity: Increasing the Gain in Pain
10.1126/science.288.5472.1765 · 2000 · External reference
Herpes Zoster and Postherpetic Neuralgia
10.2165/0002512-200825120-00002 · 2008 · External reference
Valaciclovir Compared With Acyclovir for Improved Therapy for Herpes Zoster in Immunocompetent Adults
10.1128/aac.39.7.1546 · 1995 · External reference
Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double‐Blind, Placebo‐Controlled Trial
10.7326/0003-4819-123-2-199507150-00002 · 1995 · External reference
Oral Acyclovir in Acute Herpes Zoster
10.1136/bmj.293.6561.1529 · 1986 · External reference
Antiviral Treatment for Preventing Postherpetic Neuralgia
10.1002/14651858.cd006866.pub3 · 2014 · External reference
A Network Meta‐Analysis of Randomized Clinical Trials to Assess the Efficacy and Safety of Antiviral Agents for Immunocompetent Patients With herpes Zoster‐Associated Pain
10.36076/ppj.2023.26.337 · 2023 · External reference
Antiviral Therapy of Varicella‐Zoster Virus Infections
2002 · External reference
Quantification of Risk Factors for Postherpetic Neuralgia in Herpes Zoster Patients
10.1212/wnl.0000000000002808 · 2016 · External reference
Diagnosis and Assessment of Pain Associated With Herpes Zoster and Postherpetic Neuralgia
10.1016/j.jpain.2007.10.008 · 2008 · External reference
Treatment and Prevention of Postherpetic Neuralgia
10.1086/368196 · 2003 · External reference
Treatment of Herpes Zoster
2008 · External reference
The Impact of Acute Herpes Zoster Pain and Discomfort on Functional Status and Quality of Life in Older Adults
10.1097/ajp.0b013e318065b6c9 · 2007 · External reference
A Single Dose of Gabapentin Reduces Acute Pain and Allodynia in Patients With Herpes Zoster
10.1212/01.wnl.0000168259.94991.8a · 2005 · External reference
A Randomized Trial of Acyclovir for 7 Days or 21 Days With and Without Prednisolone for Treatment of Acute Herpes Zoster
10.1056/nejm199403313301304 · 1994 · External reference
A Randomized, Placebo‐Controlled Trial of Oxycodone and of Gabapentin for Acute Pain in Herpes Zoster
10.1016/j.pain.2008.12.022 · 2009 · External reference
The Effects of Pre‐Emptive Treatment of Postherpetic Neuralgia With Amitriptyline: A Randomized, Double‐Blind, Placebo‐Controlled Trial
10.1016/s0885-3924(97)00077-8 · 1997 · External reference
Analgesic Effect of Lidocaine Patch 5% in the Treatment of Acute Herpes Zoster: A Double‐Blind and Vehicle‐Controlled Study
10.1136/rapm-00115550-200807000-00006 · 2008 · External reference
The PINE Study of Epidural Steroids and Local Anaesthetics to Prevent Postherpetic Neuralgia: A Randomised Controlled Trial
10.1016/s0140-6736(06)68032-x · 2006 · External reference
Psychosocial Risk Factors for Postherpetic Neuralgia: A Prospective Study of Patients With herpes Zoster
10.1016/j.jpain.2005.07.006 · 2005 · External reference
Burden of Herpes Zoster in the UK: Findings From the Zoster Quality of Life (ZQOL) Study
10.1186/1471-2334-14-402 · 2014 · External reference
Neuropathic Pain: Diagnosis, Pathophysiological Mechanisms, and Treatment
10.1016/s1474-4422(10)70143-5 · 2010 · External reference
Pain, Medication Use, and Health‐Related Quality of Life in Older Persons With Postherpetic Neuralgia: Results From a Population‐Based Survey
10.1016/j.jpain.2005.01.359 · 2005 · External reference
Herpes Zoster Recurrences More Frequent Than Previously Reported
10.4065/mcp.2010.0618 · 2011 · External reference
The Prognosis With Postherpetic Neuralgia
10.1016/0304-3959(91)90076-a · 1991 · External reference
Current Management of Herpes Zoster
10.2165/00128071-200506050-00005 · 2005 · External reference
Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short‐Term Persistence Substudy
10.1093/cid/cis638 · 2012 · External reference
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
10.1056/nejmoa1603800 · 2016 · External reference
Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
10.1086/528696 · 2008 · External reference
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
10.1056/nejmoa051016 · 2005 · External reference
Effectiveness of the Recombinant Zoster Vaccine in Adults Aged 50 and Older in the United States: A Claims‐Based Cohort Study
10.1093/cid/ciab121 · 2021 · External reference
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Adults With Haematological Malignancies: A Phase 3, Randomised, Clinical Trial and Post‐Hoc Efficacy Analysis
10.1016/s1473-3099(19)30163-x · 2019 · External reference
Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States
10.1016/j.ophtha.2021.04.017 · 2021 · External reference
